Neoleukin Therapeutics (NLTX) Insider Trading
- $37,453,647.58
- $412,681.65
- Aug. 17, 2023
- Carl Walkey
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 17, 2023 | Director | 166,942 | $0.69 | Buy | $115,189.98 | |
Aug. 15, 2023 | Director | 1,888,800 | $0.63 | Buy | $1,189,944.00 | |
Aug. 11, 2023 | CFO | 1,323 | $0.62 | Sell | $820.26 | |
April 3, 2023 | Insider | 3,769 | $0.69 | Sell | $2,600.61 | |
Aug. 10, 2022 | Insider | 1,655 | $0.99 | Sell | $1,638.45 | |
May 2, 2022 | Insider | 5,538 | $1.22 | Sell | $6,756.36 | |
Aug. 24, 2021 | CEO | 100,000 | $6.11 | Buy | $611,000.00 | |
June 16, 2021 | SVP | 600 | $10.19 | Sell | $6,114.00 | |
June 8, 2021 | SVP | 600 | $11.00 | Sell | $6,600.00 | |
June 4, 2021 | SVP | 600 | $10.00 | Sell | $6,000.00 | |
June 3, 2021 | CEO | 40,000 | $9.48 | Buy | $379,200.00 | |
May 26, 2021 | SVP | 600 | $10.00 | Sell | $6,000.00 | |
May 19, 2021 | SVP | 600 | $10.63 | Sell | $6,378.00 | |
May 12, 2021 | SVP | 1,200 | $11.09 | Sell | $13,308.00 | |
May 5, 2021 | SVP | 1,200 | $11.30 | Sell | $13,560.00 | |
April 28, 2021 | SVP | 2,400 | $12.58 | Sell | $30,192.00 | |
April 26, 2021 | SVP | 600 | $13.00 | Sell | $7,800.00 | |
April 21, 2021 | SVP | 1,800 | $11.98 | Sell | $21,564.00 | |
April 14, 2021 | SVP | 1,800 | $12.22 | Sell | $21,996.00 | |
April 7, 2021 | SVP | 1,800 | $12.02 | Sell | $21,636.00 | |
April 5, 2021 | SVP | 600 | $13.00 | Sell | $7,800.00 | |
March 31, 2021 | SVP | 1,800 | $11.96 | Sell | $21,528.00 | |
March 24, 2021 | SVP | 1,800 | $11.95 | Sell | $21,510.00 | |
March 22, 2021 | SVP | 600 | $12.00 | Sell | $7,200.00 | |
March 17, 2021 | SVP | 1,200 | $11.36 | Sell | $13,632.00 | |
March 17, 2021 | CFO | 6,497 | $11.01 | Sell | $71,531.97 | |
March 10, 2021 | SVP | 1,800 | $11.97 | Sell | $21,546.00 | |
March 3, 2021 | SVP | 1,800 | $11.87 | Sell | $21,366.00 | |
Feb. 24, 2021 | SVP | 1,800 | $12.14 | Sell | $21,852.00 | |
Feb. 3, 2021 | SVP | 2,400 | $13.23 | Sell | $31,752.00 | |
July 7, 2020 | Director | 424,000 | $15.25 | Buy | $6,466,000.00 | |
April 2, 2020 | Major Shareholder | 39,300 | $11.37 | Buy | $446,841.00 | |
March 30, 2020 | Major Shareholder | 32,500 | $9.94 | Buy | $323,050.00 | |
March 27, 2020 | Major Shareholder | 50,000 | $9.21 | Buy | $460,500.00 | |
Dec. 20, 2019 | CEO | 119,047 | $8.40 | Buy | $999,994.80 | |
Dec. 20, 2019 | Director | 3,017,542 | $8.40 | Buy | $25,347,352.80 | |
Aug. 7, 2019 | Director | 371,525 | $3.00 | Buy | $1,114,575.00 |
Insiders are both buying and selling Neoleukin Therapeutics stock.
The insider traders at Neoleukin Therapeutics are: Carl Walkey, Bros. Advisors Lp Baker, Redmile Group, Llc, Sean Michael Smith, Jonathan G Drachman, Priti Patel, Robert Ho, and Jonathan G. Drachman
The most active insider trader at Neoleukin Therapeutics is Carl Walkey with 21 trades.
Carl Walkey has sold the most Neoleukin Therapeutics stock with a total value of $335,448.00.
Bros. Advisors Lp Baker has bought the most Neoleukin Therapeutics stock with a total value of $34,348,251.76.
The most recent insider trade for Neoleukin Therapeutics was on Aug. 17, 2023.
The single biggest insider buy for Neoleukin Therapeutics was from Bros. Advisors Lp Baker with a total value of $25,347,352.80 on Dec. 20, 2019.
The single biggest insider sell for Neoleukin Therapeutics was from Robert Ho with a total value of $71,531.97 on March 17, 2021.